HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsunori Imai Selected Research

HLA-A24 Antigen

4/2011A novel tumor-associated antigen, cell division cycle 45-like can induce cytotoxic T-lymphocytes reactive to tumor cells.
9/2010Identification of SPARC as a candidate target antigen for immunotherapy of various cancers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsunori Imai Research Topics

Disease

77Neoplasms (Cancer)
11/2022 - 09/2007
54Hepatocellular Carcinoma (Hepatoma)
11/2022 - 09/2007
37Neoplasm Metastasis (Metastasis)
04/2022 - 11/2012
13Cholangiocarcinoma
10/2021 - 05/2010
12Pancreatic Neoplasms (Pancreatic Cancer)
06/2022 - 10/2008
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2008
7Inflammation (Inflammations)
07/2022 - 12/2017
7Lymphatic Metastasis
06/2022 - 12/2017
7Liver Diseases (Liver Disease)
08/2021 - 12/2012
6Adenocarcinoma
01/2022 - 01/2018
5Fibrosis (Cirrhosis)
01/2022 - 11/2014
4Colonic Neoplasms (Colon Cancer)
04/2022 - 11/2012
4Ascites
06/2021 - 10/2012
3Carcinogenesis
12/2021 - 12/2017
3Klatskin Tumor
09/2020 - 12/2016
3Disease Progression
02/2020 - 01/2016
3Thrombosis (Thrombus)
01/2019 - 09/2007
3Lung Neoplasms (Lung Cancer)
04/2011 - 12/2008
2Rectal Neoplasms (Rectal Cancer)
04/2022 - 06/2014
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2022 - 05/2014
2Chronic Hepatitis C
04/2021 - 04/2020
2Liver Abscess
08/2020 - 01/2018
2False Aneurysm (Pseudoaneurysm)
08/2020 - 05/2017
2Hemorrhage
08/2020 - 05/2017
2Residual Neoplasm
01/2020 - 01/2018
2Hepatic Insufficiency
09/2019 - 01/2019
2Stomach Neoplasms (Stomach Cancer)
01/2018 - 12/2016
2Liver Neoplasms (Liver Cancer)
01/2018 - 02/2016
2Dysbiosis
12/2017 - 01/2017
2Carcinoma (Carcinomatosis)
03/2017 - 08/2012
1Rectal Diseases (Rectal Disease)
04/2022
1Colonic Diseases
04/2022
1Surgical Wound Infection
02/2022
1Wounds and Injuries (Trauma)
02/2022

Drug/Important Bio-Agent (IBA)

15AntigensIBA
06/2022 - 10/2008
10Tumor Biomarkers (Tumor Markers)IBA
03/2021 - 08/2012
9CarbohydratesIBA
01/2022 - 12/2015
8Carcinoembryonic AntigenIBA
03/2021 - 10/2014
7AlbuminsIBA
01/2022 - 01/2018
6Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2018
5Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2010
5Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020 - 03/2013
5Fluorouracil (Carac)FDA LinkGeneric
01/2020 - 03/2013
5Fetal Proteins (Fetoprotein)IBA
02/2019 - 01/2018
5Prothrombin (Factor II)IBA
01/2019 - 09/2017
5Peptides (Polypeptides)IBA
04/2011 - 10/2008
5Complementary DNA (cDNA)IBA
04/2011 - 10/2008
4Messenger RNA (mRNA)IBA
06/2022 - 05/2010
4Biological ProductsIBA
04/2022 - 01/2020
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
04/2021 - 05/2018
4GemcitabineFDA Link
02/2020 - 08/2012
4DNA (Deoxyribonucleic Acid)IBA
06/2019 - 01/2017
3Codon (Codons)IBA
04/2022 - 11/2019
3Human Serum AlbuminFDA LinkGeneric
10/2021 - 05/2014
3lentil lectinIBA
04/2021 - 01/2019
3Histones (Histone)IBA
01/2021 - 12/2013
3C-Reactive ProteinIBA
12/2020 - 01/2018
3EnzymesIBA
05/2020 - 01/2008
3Cisplatin (Platino)FDA LinkGeneric
01/2019 - 12/2016
3EpitopesIBA
04/2011 - 12/2008
3HLA-A2 Antigen (HLA A2 Antigen)IBA
01/2011 - 10/2008
2Capsules (Microcapsules)IBA
05/2022 - 10/2021
2BilirubinIBA
01/2022 - 08/2014
2Oxygen (Dioxygen)IBA
08/2021 - 12/2016
2Bevacizumab (Avastin)FDA Link
06/2020 - 12/2015
2Serum AlbuminIBA
02/2020 - 12/2014
2Small Interfering RNA (siRNA)IBA
01/2020 - 09/2015
2Irinotecan (Camptosar)FDA LinkGeneric
01/2020 - 01/2014
2Indocyanine Green (Cardio-Green)FDA LinkGeneric
11/2019 - 09/2014
2acarboxyprothrombin (PIVKA)IBA
02/2019 - 05/2018
2ProstaglandinsIBA
01/2019 - 02/2018
215-hydroxyprostaglandin dehydrogenaseIBA
01/2019 - 02/2018
2Enhancer of Zeste Homolog 2 ProteinIBA
10/2018 - 12/2013
2Sorafenib (BAY 43-9006)FDA Link
04/2018 - 12/2016
2Bile Acids and Salts (Bile Acids)IBA
12/2017 - 12/2012
2Indicators and Reagents (Reagents)IBA
06/2017 - 11/2014
2Pharmaceutical PreparationsIBA
12/2016 - 01/2014
2Leucovorin (Folinic Acid)FDA Link
12/2015 - 01/2014
2Cadherins (E-Cadherin)IBA
09/2015 - 10/2008
2Therapeutic UsesIBA
10/2014 - 09/2007
2HLA-A24 AntigenIBA
04/2011 - 09/2010
1Dihydrotachysterol (AT 10)IBA
04/2022
1PlasticsIBA
02/2022

Therapy/Procedure

56Hepatectomy
11/2022 - 06/2012
24Drug Therapy (Chemotherapy)
06/2022 - 09/2007
22Therapeutics
01/2022 - 09/2007
15Radiofrequency Ablation
05/2021 - 05/2014
9Immunotherapy
01/2019 - 10/2008
8Pancreaticoduodenectomy
01/2022 - 05/2017
5Adjuvant Chemotherapy
06/2022 - 03/2013
4Pancreatectomy
01/2022 - 01/2017
3Erythrocyte Transfusion
01/2022 - 01/2018
3Punctures
07/2020 - 12/2012
3Lymph Node Excision (Lymph Node Dissection)
04/2019 - 01/2017
2Catheters
08/2020 - 06/2012
2Operative Surgical Procedures
07/2020 - 11/2016
2Conservative Treatment
01/2020 - 10/2012
2Ligation
09/2019 - 08/2018
1Activities of Daily Living (ADL)
11/2022
1Perioperative Period
02/2022